banner
Lipopolysaccharides from Escherichia coli O111:B4, purified by trichloroacetic acid extraction
Inquiry

Cat. No.: XGB676

Lipopolysaccharides from Escherichia coli O111:B4, purified by trichloroacetic acid extraction

Synonym: LPS

  • MDL: MFCD00164401
  • NACRES: NA.25
img
Product Size
100 mg;500 mg
Price
Datasheet
MSDS
Properties
Biological Source
Escherichia coli (O111:B4)
Form
lyophilized powder
Purity
purified by trichloroacetic acid extraction
Impurities
1-10% Protein (Lowry)
Applications
Lipopolysaccharides (LPSs) are characteristic components of the cell wall of Gram-negative bacteria. LPS and its lipid A part stimulate the cells of the innate immune system through Toll-like receptor 4 (TLR4), which can recognize common pathogen-related molecular patterns (PAMP). This LPS serotype has been used to stimulate B-cells and induce NOS in human hepatocytes.
Safety Information
WGK Germany
WGK 3
Hazard Statements
H300
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.
0